USPH Stock Forecast & Price Target

US Physical Therapy Inc is experiencing strong momentum in its industrial injury prevention business, which is positively impacting overall revenue projections, with expectations for 17.1% growth in that segment compared to the prior year. The company recently increased its adjusted EBITDA guidance for FY/25 to a range of $93 million to $97 million, reflecting an expected growth of approximately 8.6% year-over-year. Additionally, US Physical Therapy's operational developments indicate a significant 180-basis point improvement in key financial metrics from the comparable period, further underscoring its favorable outlook.

The anticipated lack of pricing headwinds in 2026 relative to the Medicare business may not be sufficient to counteract existing financial challenges faced by US Physical Therapy Inc. The company is heavily reliant on various payment sources, which may be impacted by ongoing changes in healthcare policies and reimbursement rates, potentially limiting revenue growth. Additionally, the primary revenue generation from the Physical therapy operations segment could face pressures due to increased competition and fluctuating demand for outpatient services post-pandemic.